Utilizing Cry1−/− and Cry2−/− mice, we demonstrate for the first time that Cry1−/− loss interferes with HFD-induced obesity, and that the physiological basis of this effect is not related to reduced energy intake. Here, CRY2 is linked to obesity due to melanocortin 4 receptor deficiency.